Detalhe da pesquisa
1.
Fatty acid binding protein 7 may be a marker and therapeutic targets in clear cell renal cell carcinoma.
BMC Cancer
; 18(1): 1114, 2018 Nov 15.
Artigo
Inglês
| MEDLINE | ID: mdl-30442117
2.
Urinary cytokines in patients treated with intravesical mitomycin-C with and without hyperthermia.
World J Urol
; 33(10): 1411-7, 2015 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-25491674
3.
Combination of sunitinib and 177Lu-labeled antibody cG250 targeted radioimmunotherapy: A promising new therapeutic strategy for patients with advanced renal cell cancer.
Neoplasia
; 32: 100826, 2022 10.
Artigo
Inglês
| MEDLINE | ID: mdl-35878454
4.
Circulating tumour tissue fragments in patients with pulmonary metastasis of clear cell renal cell carcinoma.
J Pathol
; 219(3): 287-93, 2009 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-19731255
5.
Targeted Dual-Modality Imaging in Renal Cell Carcinoma: An Ex Vivo Kidney Perfusion Study.
Clin Cancer Res
; 22(18): 4634-42, 2016 09 15.
Artigo
Inglês
| MEDLINE | ID: mdl-27103404
6.
Strict regulation of CAIX(G250/MN) by HIF-1alpha in clear cell renal cell carcinoma.
Oncogene
; 23(33): 5624-31, 2004 Jul 22.
Artigo
Inglês
| MEDLINE | ID: mdl-15184875
7.
Successful combination of sunitinib and girentuximab in two renal cell carcinoma animal models: a rationale for combination treatment of patients with advanced RCC.
Neoplasia
; 17(2): 215-24, 2015 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-25748241
8.
Neoadjuvant sorafenib treatment of clear cell renal cell carcinoma and release of circulating tumor fragments.
Neoplasia
; 16(3): 221-8, 2014 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-24726142
9.
Tyrosine kinase inhibitor sorafenib decreases 111In-girentuximab uptake in patients with clear cell renal cell carcinoma.
J Nucl Med
; 55(2): 242-7, 2014 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-24396030
10.
Renal cell carcinoma-associated G250 methylation and expression: in vivo and in vitro studies.
Urology
; 60(2): 357-62, 2002 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-12137853